RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
MicroPort Orthopedics, a US division of Shanghai’s medical device maker, MicroPort Scientific, launched the Evolution® NitrX™ Medial-Pivot Knee System, the latest version of its knee replacement product. The newest NitrX™ product features a titanium niobium nitride (TiNbN) coating that has been shown to reduce the release of trace metals. Clinicians say the new product speeds patient recovery. In 2014, MicroPort acquired US-based Wright Medical’s joint replacement business and says it is now the world’s fourth-largest multinational orthopedics company.
Source: China Biotoday
